BioNTech: News
Trials of world's first lung cancer vaccine are now underway
The world's first mRNA lung cancer vaccine, BNT116, is currently being trialed in patients across seven countries.
Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine
Pfizer and BioNTech have begin the clinical trial for a vaccine against the Omicron variant of coronavirus, the companies said on Tuesday.
Pfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity'
The COVID-19 vaccine developed by Pfizer and BioNTech has been found safe for children between five to 11 years of age and generates a "robust" immune response, the companies said on Monday.
England school children aged 12-15yrs to be offered COVID-19 vaccine
School children aged between 12 and 15 years will be offered a first dose of the Pfizer/BioNTech COVID-19 vaccine starting next week, the UK government has announced after the country's Chief Medical Officers gave their go-ahead for the jabs for younger age groups.
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
The Pfizer-BioNTech COVID-19 vaccine has finally received full approval from the US Food and Drug Administration (FDA) on Monday for use in people aged 16 and above in the country.
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
The United States Food and Drug Administration (FDA) is reportedly set to grant full approval to Pfizer-BioNTech's two-dose COVID-19 vaccine next week, expediting the previous timeline for licensing the vaccine.
Pfizer-BioNTech's coronavirus vaccine being tested on children under 12
American pharma giant Pfizer and German company BioNTech began testing their coronavirus vaccine on children, aged under 12, reports Reuters.
Norway raises COVID-19 vaccine concerns for elderly after 29 deaths
Norway has expressed concern over the safety of the COVID-19 vaccine developed by Pfizer and BioNTech among older populations as 29 people died after receiving the shot.
WHO approves Pfizer-BioNTech's coronavirus vaccine for emergency use
The World Health Organization (WHO) on Thursday granted "emergency validation" to the coronavirus vaccine developed by Pfizer and BioNTech, making it the first vaccine to be given such an approval by the United Nations body.
Can prepare vaccine against mutated virus in 6 weeks: BioNTech
Ugur Sahin, the co-founder and CEO of the German drugmaker BioNTech, displayed confidence that their COVID-19 vaccine can work against the new strain of the coronavirus.
Ian 'Magneto' McKellen gets first COVID-19 vaccine dose, is 'euphoric'
Our very own metal-bending mutant Magneto has been given the power to fight coronavirus, thanks to the vaccine.
Coronavirus vaccine could turn you into 'crocodile': Brazil's President
Jair Bolsonaro, the President of Brazil, who tested positive for coronavirus twice, has given a bizarre statement about vaccines. He suggested that the one developed by Pfizer and BioNTech could turn people into "crocodiles," and that the company won't take any responsibility.
COVID-19 vaccine: India to produce 300 million Sputnik V doses
India will reportedly produce around 300 million doses of the Russian COVID-19 vaccine called Sputnik V.
US angling to secure more of Pfizer's coronavirus vaccine
U.S. officials have said that they are actively negotiating for additional purchases of Pfizer's coronavirus vaccine after they missed the chance to lock in a contract this summer since it was still unclear how well the shots would work.
Talk show host Ellen DeGeneres has tested positive for COVID-19
The world needs to "be kind" to Ellen DeGeneres, as she needs kindness and a lot of prayers from her fans now.
Pfizer vaccine: UK issues allergy warning after two adverse reactions
British medicine regulator on Wednesday advised people with a history of significant allergic reactions against getting the COVID-19 vaccine developed by Pfizer and BioNTech.
COVID-19 vaccine: 90-year-old woman receives first Pfizer shot in UK
A 90-year-old woman in the United Kingdom has become the world's first person to receive the COVID-19 vaccine developed by Pfizer and BioNTech outside of clinical trials.
Pfizer seeks emergency approval for COVID-19 vaccine in India
United States-based pharmaceutical giant Pfizer has sought emergency approval for its COVID-19 vaccine from India's drug regulator.
Putin orders Russian authorities to start mass COVID-19 vaccinations
Russian President Vladimir Putin on Wednesday ordered authorities to start mass voluntary vaccinations for COVID-19.
UK approves Pfizer-BioNTech's COVID-19 vaccine; first doses expected next week
The United Kingdom on Wednesday gave emergency approval to Pfizer and BioNTech's COVID-19 vaccine, becoming the first Western country to allow mass immunization against the viral disease.
Deliveries of Pfizer-BioNTech's coronavirus vaccine could start before Christmas
The world, battered by coronavirus pandemic, would get relief as early as Christmas, as the vaccine developed by Pfizer and BioNTech could be out by then, an official from the German company said.
Pfizer's COVID-19 vaccine '95% effective'; to seek emergency US authorization
Pharmaceutical giant Pfizer and German drugmaker BioNTech on Wednesday said their COVID-19 vaccine has been found 95% effective in final trials.
Moderna's COVID-19 vaccine found to be 95% effective: Details here
American biotech company Moderna Therapeutics has announced that its COVID-19 vaccine was found to be nearly 95% effective in preventing the novel coronavirus disease.
Meet the husband-wife duo behind Pfizer-BioNTech's COVID-19 vaccine
United States pharmaceutical giant Pfizer and German biotech firm BioNTech had on Monday announced that their COVID-19 vaccine candidate is over 90% effective based on initial data from a large study.
Trump says Pfizer withheld announcement on COVID-19 vaccine before election
United States President Donald Trump has accused pharmaceutical giant Pfizer and the US Food and Drug Administration of delaying the announcement on a COVID-19 vaccine until after the 2020 Presidential election.
Pfizer, BioNTech say their COVID-19 vaccine is over 90% effective
United States pharmaceutical giant Pfizer and German biotech firm BioNTech have said their COVID-19 vaccine is over 90% effective, according to initial data from a large study.
Pfizer's COVID-19 vaccine shows promise in human trials: Details here
The COVID-19 candidate vaccine jointly developed by American pharma giant Pfizer and German biotech company BioNTech has shown promise in early human trials.